Literature DB >> 9672266

Is tamoxifen effective in prevention of breast cancer?

K I Pritchard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9672266     DOI： 10.1016/S0140-6736(98)85002-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

Authors:  B S Shoker; C Jarvis; R B Clarke; E Anderson; J Hewlett; M P Davies; D R Sibson; J P Sloane
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump.

Authors:  Rebecca Taylor; Kenneth Taguchi
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

Review 3.  Antiestrogens--tamoxifen, SERMs and beyond.

Authors:  K Dhingra
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 4.  Breast cancer prevention trials.

Authors:  D J Rhodes; L C Hartmann; E A Perez
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

5.  Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.

Authors:  Abeer M Shaaban; John P Sloane; Christopher R West; Christopher S Foster
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 6.  Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention.

Authors:  H S Feigelson; B E Henderson
Journal:  Breast Cancer Res       Date:  2000-05-24       Impact factor: 6.466

7.  First do no harm: extending the debate on the provision of preventive tamoxifen.

Authors:  B P Will; K M Nobrega; J M Berthelot; W Flanagan; M C Wolfson; D M Logan; W K Evans
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.